Inova Schar Cancer’s pulmonary nodule program saves lives

Study at a glance Inova’s incidental lung nodule program has shown a 76% reduction in time from identification to diagnosis compared to standard referral pathways. This study showed an improvement in early-stage diagnosis of lung cancer when identified through Inova’s incidental lung nodule program. • 9,303 patients identified with incidental lung nodules • 134-day reduction… The post Inova Schar…